Immunic Inc’s filing revealed that its Executive Chairman Nash Duane acquired Company’s shares for reported $16694.0 on Jun 13 ’25. In the deal valued at $0.83 per share,20,000 shares were bought. As a result of this transaction, Nash Duane now holds 36,032 shares worth roughly $33870.079999999994.
Then, Tardio Jason bought 12,512 shares, generating $9,884 in total proceeds. Upon buying the shares at $0.79, the President and COO now owns 12,512 shares.
Before that, Vitt Daniel bought 15,000 shares. Immunic Inc shares valued at $11,550 were divested by the CEO and Director at a price of $0.77 per share. As a result of the transaction, Vitt Daniel now holds 29,000 shares, worth roughly $27260.0.
Chardan Capital Markets initiated its Immunic Inc [IMUX] rating to a Buy in a research note published on September 29, 2025; the price target was $13. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late March with a ‘”an Outperform”‘ rating. H.C. Wainwright began covering IMUX with “Buy” recommendation on November 25, 2024.
Price Performance Review of IMUX
On Monday, Immunic Inc [NASDAQ:IMUX] saw its stock fall -3.91% to $0.94. Over the last five days, the stock has gained 0.56%. Immunic Inc shares have fallen nearly -40.88% since the year began. Nevertheless, the stocks have fallen -6.00% over the past one year. While a 52-week high of $1.73 was reached on 02/21/25, a 52-week low of $0.56 was recorded on 05/29/25.
Levels Of Support And Resistance For IMUX Stock
The 24-hour chart illustrates a support level at 0.9117, which if violated will result in even more drops to 0.8834. On the upside, there is a resistance level at 0.9830. A further resistance level may holdings at 1.0260.
How much short interest is there in Immunic Inc?
A steep rise in short interest was recorded in Immunic Inc stocks on 2025-09-15, growing by 0.36 million shares to a total of 10.01 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 9.65 million shares. There was a rise of 3.64%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 27, 2024 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $6 price target.
